Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

François Rozet

14PUBLICATIONS
96CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersCancer diagnosisBiological physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

Sort by Publication Date:
|May 26, 2026
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.

|Feb 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 Trial.

Nadine Houédé, Thierry Chevallier, François Audenet

|May 30, 2024
A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinoma.

Pierre-Etienne Gabriel, Géraldine Cancel-Tassin, François Audenet

|Feb 19, 2024
Scoring system for prediction of overall survival in patients with renal cell carcinoma T3aN0M0.

Caio Vinícius Suartz, Maurício Dener Cordeiro, Paulo Afonso de Carvalho

|Jan 02, 2023
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.

Yanish Soorojebally, Yann Neuzillet, Mathieu Roumiguié

|Dec 03, 2022
A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancer.

Yann Neuzillet, Priscilla Leon, Thomas Seisen

Pageof 3

Frequent Collaborators

3 joint publications

Gwenaelle Gravis

3 joint publications

Constance Thibault

2 joint publications

Yohann Loriot

2 joint publications

Mathieu Roumiguié

2 joint publications

Priscilla Leon

2 joint publications

Yves Allory

2 joint publications

Alexandra Masson-Lecomte

1 joint publications

Wenhuo Hu

1 joint publications

Alex Penson

1 joint publications

Benjamin Gordon

Frequent Collaborators

3 joint publications

Gwenaelle Gravis

3 joint publications

Constance Thibault

2 joint publications

Yohann Loriot

2 joint publications

Mathieu Roumiguié